Skip to content
Checked.be
Complete company report
Generated 31-07-2026
Active BE 0448.505.234Public limited company

IBIS PHARMA

Generaal Wahislaan 20a ·1030 Schaarbeek, Belgium· 33 yrs active
Sector: Retail trade (47730)
Conclusion Checked

The computed 12-month bankruptcy probability of IBIS PHARMA is 1.1% (low). The company has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 33 yrs
Board 3
Locations 2
Publications 5
Bankruptcy probability (12 mo) Checked model v1 · free
1.1% Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region +Long track record −Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Long-established
Founded in 1992, 33 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 27-05-2025 2025-00108088
31-12-2023 volledig 24-07-2024 2024-00283472
31-12-2022 volledig 22-05-2023 2023-00093463
31-12-2021 volledig 04-07-2022 2022-20139557
31-12-2020 volledig 09-06-2021 2021-18900222
31-12-2019 volledig 09-07-2020 2020-28900018
31-12-2018 volledig 27-08-2019 2019-51600344
31-12-2017 volledig 27-07-2018 2018-39600239
31-12-2016 volledig 28-08-2017 2017-51000189
31-12-2015 volledig 13-07-2016 2016-32100423
Directors & mandates 3 directors
Directors derived from a single State Gazette act, under verification
All 3 current directors first appear in the same act (25356945). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.
Current directors & mandates
  • DELEGLISE Jean-Pierre
    Director
    State Gazette act 25356945 (22-09-2025)
    Current
    03-05-2016 → present
    2 events
    • 09-09-2025 Mandate renewed· Director
    • 03-05-2016 Mandate renewed· Director
  • DASSAS Serge
    Director
    State Gazette act 25356945 (22-09-2025)
    Current
    30-07-2015 → present
    2 events
    • 09-09-2025 Mandate renewed· Director
    • 30-07-2015 Mandate renewed· Director
  • MARECHAL Philippe
    Director
    State Gazette act 25356945 (22-09-2025)
    Current
    30-07-2015 → present
    4 events
    • 09-09-2025 Mandate renewed· Director
    • 09-09-2025 Appointed· Managing director
    • 03-05-2016 Mandate renewed· Managing director
    • 30-07-2015 Mandate renewed· Managing director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Legal Structure
NACE primary Retail trade(47730)
Legal form Public limited company(014)
Incorporation27-10-1992
StatusActive
Postal code1030
Establishment units 2 locations
Rue du Basteau,Forrières 5, 6953 Nassogne
Groothandel in farmaceutische producten
since 19922.059.479.848
Generaal Wahislaan 20 A, 1030 Schaarbeek
Groothandel in farmaceutische producten
since 19932.059.479.749
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
21904B0384/00M000 Brussels 1,988 m² 1 · 643 m² 25.1 m · 7 fl.
83015B0212/00P000 Wallonia 1,397 m² 1 · 120 m² 9.9 m · 2 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 15 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
12-06-2026
State Gazette act Open capture
General meeting · Auditor mandate · Permanent representative · Act object
2025
22-09-2025
State Gazette act Director changes
v3.2
27-05-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
24-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
12-02-2024
State Gazette act End of life
v3.2
2023
22-05-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
2022
04-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
09-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
2020
09-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2019
27-08-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
27-07-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
2017
28-08-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
2016
14-07-2016
State Gazette act Director changes
v3.2
13-07-2016
NBB filing Annual accounts filed
fiscal year 2015 · volledig
2015
30-07-2015
State Gazette act Director changes
v3.2
Belgisch Staatsblad, acts 5 acts
All acts · 5 updated 1 month ago
2026
12-06-2026 General meeting · Auditor mandate · Permanent representative · Act object Open-capture extraction
  • Filing: 2026-06-05 · IBIS PHARMA
  • Publication: 2026-06-12 · IBIS PHARMA
  • General meeting: date: 2025-05-13, type: extraordinaire · IBIS PHARMA
  • Auditor mandate: end_date: 2027-12-31, start_date: 2025-05-13 · IBIS PHARMA
  • Permanent representative: role: représentant · DGST & Partners - Réviseurs d'entreprises
  • Act object: NOMINATION REVISEUR
Summary: General meeting · Auditor mandate · Permanent representative · Act object
Technical details 
{
  "facts": [
    {
      "type": "filing",
      "quote": "Depos\u00E9/Recu le 5 JUIN 2026 au greffe du tribunal de l\u0027entreprise",
      "value": "2026-06-05",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 12/06/2026 - Annexes du Moniteur belge",
      "value": "2026-06-12",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "general_meeting",
      "quote": "Lors de la tenue d\u0027une assembl\u00E9e g\u00E9n\u00E9rale extraordinaire tenue le 13 mai 2025 au si\u0117ge de la soci\u00E9t\u00E9",
      "value": {
        "date": "2025-05-13",
        "type": "extraordinaire"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "auditor_mandate",
      "quote": "a \u00E9t\u00E9 nomm\u00E9e aux fonctions de commissaire la SRL \u0022DGST \u0026 Partners - R\u00E9viseurs d\u0027entreprises\u0022 ... Le mandat de commissaire s\u0027ach\u00E8vera avec les comptes annuels cl\u00F4tures au 31/12/2027.",
      "value": {
        "end_date": "2027-12-31",
        "start_date": "2025-05-13"
      },
      "object": "e2",
      "subject": "e1"
    },
    {
      "type": "permanent_representative",
      "quote": "laquelle a d\u00E9clar\u00E9 d\u00E9signer comme repr\u00E9sentant Michel Lecocq, r\u00E9viseur d\u0027entreprises.",
      "value": {
        "role": "repr\u00E9sentant"
      },
      "object": "e3",
      "subject": "e2"
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: NOMINATION REVISEUR",
      "value": "NOMINATION REVISEUR",
      "object": null,
      "subject": null
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 1344,
    "truncated": false,
    "needs_verify": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0448.505.234",
      "kind": "company",
      "name": "IBIS PHARMA",
      "attrs": {
        "seat": "BOULEVARD GENERAL WAHIS 20A - 1030 SCHARBEEK",
        "legal_form": "SOCIETE ANONYME"
      }
    },
    {
      "id": "e2",
      "kbo": "0458.736.952",
      "kind": "org",
      "name": "DGST \u0026 Partners - R\u00E9viseurs d\u0027entreprises",
      "attrs": {
        "seat": "1170 Bruxelles, avenue E. Van Bevelaere, 28A/71",
        "legal_form": "SRL",
        "operational_seat": "rue de la Concorde 27 \u00E0 4800 Verviers"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Michel Lecocq",
      "attrs": {
        "role": "repr\u00E9sentant"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Philippe MARECHAL",
      "attrs": {
        "role": "Administrateur-d\u00E9l\u00E9gu\u00E9"
      }
    }
  ]
}
2025
22-09-2025 3 reappointed Director changes
  • MARECHAL Philippe, Bestuurder
  • DASSAS Serge, Bestuurder
  • DELEGLISE Jean-Pierre, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MARECHAL Philippe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-09-09",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale a accept\u00E9 la d\u00E9mission de administrateurs actuels, - Monsieur MARECHAL Philippe ; ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale leur a donn\u00E9 pleine et enti\u00E8re d\u00E9charge pour l\u2019exercice de leur mandat depuis la derni\u00E8re assembl\u00E9e g\u00E9n\u00E9rale. ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de les renommer en qualit\u00E9 d",
      "discharge_granted": true
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DASSAS Serge",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-09-09",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale a accept\u00E9 la d\u00E9mission de administrateurs actuels, ... - Monsieur DASSAS Serge ; ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale leur a donn\u00E9 pleine et enti\u00E8re d\u00E9charge pour l\u2019exercice de leur mandat depuis la derni\u00E8re assembl\u00E9e g\u00E9n\u00E9rale. ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de les renommer en qualit\u00E9 d\u2019",
      "discharge_granted": true
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DELEGLISE Jean-Pierre",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-09-09",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale a accept\u00E9 la d\u00E9mission de administrateurs actuels, ... - Monsieur DELEGLISE Jean-Pierre. ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale leur a donn\u00E9 pleine et enti\u00E8re d\u00E9charge pour l\u2019exercice de leur mandat depuis la derni\u00E8re assembl\u00E9e g\u00E9n\u00E9rale. ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de les renommer en qu",
      "discharge_granted": true
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0448.505.234",
    "name_full": "IBIS PHARMA",
    "legal_form": "SA"
  }
}
2024
12-02-2024 End of the company published End of life
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "final_status": null,
  "subject_company": {
    "kbo": "0448.505.234"
  }
}
2016
14-07-2016 2 reappointed Director changes
  • Jean-Pierre DELEGLISE, Bestuurder
  • Philippe MARECHAL, Gedelegeerd bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Pierre DELEGLISE",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-05-03",
      "evidence_quote": "En date du 3 mai 2016, l\u0027Assembl\u00E9e G\u00E9n\u00E9rale des actionnaires a accept\u00E9 le renouvellement du mandat pour une dur\u00E9e de 5 ans qui prendra fin lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale statuant sur les comptes arr\u00EAt\u0117s aui 31/12/2020 de : - Jean-Pierre DELEGLISE domicili\u00E9 Zevengatenlaan n\u00B044 \u00E0 1652 Alsemberg en quali"
    },
    {
      "kind": "director_renew",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe MARECHAL",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-05-03",
      "evidence_quote": "En date du 3 mai 2016, l\u0027Assembl\u00E9e G\u00E9n\u00E9rale des actionnaires a accept\u00E9 le renouvellement du mandat pour une dur\u00E9e de 5 ans qui prendra fin lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale statuant sur les comptes arr\u00EAt\u0117s aui 31/12/2020 de : - Jean-Pierre DELEGLISE domicili\u00E9 Zevengatenlaan n\u00B044 \u00E0 1652 Alsemberg en quali"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0448.505.234",
    "name_full": "IBIS PHARMA",
    "legal_form": "SA"
  }
}
2015
30-07-2015 2 reappointed Director changes
  • Philippe MARECHAL, Gedelegeerd bestuurder
  • Serge DASSAS, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe MARECHAL",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "En date du 5 mai 2015, l\u0027Assembl\u00E9e G\u00E9n\u00E9rale des actionna\u00EDres a accept\u00E9 le renouvellement des mandats pour une dur\u00E9e de.6 ans qui prendra fin lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale statuant sur les comptes arr\u00EAt\u00E9s au 31/12/2020 de : Philippe MARECHAL domicili\u00E9 rue Pierre Van dyck 3 bte A \u00E0 1310 La Hulpe en qua"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Serge DASSAS",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "En date du 5 mai 2015, l\u0027Assembl\u00E9e G\u00E9n\u00E9rale des actionna\u00EDres a accept\u00E9 le renouvellement des mandats pour une dur\u00E9e de.6 ans qui prendra fin lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale statuant sur les comptes arr\u00EAt\u00E9s au 31/12/2020 de : ... Serge DASSAS domicili\u00E9 Avenue des 10 Arpents n\u00B0 36 \u00E0 1200 Woluw\u00E9-Saint-Lam"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0448.505.234",
    "name_full": "IBIS PHARMA",
    "legal_form": "SA"
  }
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE) Crossroads Bank
Activities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Apotheken47730Detailhandel in farmaceutische producten47730Groothandel in farmaceutische producten51460Apothekers52310
Primary activity highlighted.
Names & trade names
Legal nameFR IBIS PHARMA
Registered office
Generaal Wahislaan 20a
1030 Schaarbeek, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
ALPHAR BE 0426.424.371 · Schaarbeek
EL RASS BE 0426.283.623 · Schaarbeek
PHARMACIE APPART BE 0426.161.085 · Schaarbeek
Pharmacie des Croisades BE 0426.479.108 · Schaarbeek
PHARMACIE SAINTE-MARIE BE 0401.948.796 · Schaarbeek
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative